The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 20 , ISSUE 12 ( December, 2019 ) > List of Articles

ORIGINAL RESEARCH

Adjunctive Effect of Doxycycline with Conventional Periodontal Therapy on Glycemic Level for Chronic Periodontitis with Type 2 Diabetes Mellitus Subjects

Abhaya C Das, Swarga J Das, Saurav Panda, Dipti Sharma, Silvio Taschieri, Massimo D Fabbro

Keywords : Diabetes, Doxycycline, Glycated hemoglobin, Periodontitis, Root planing, Scaling

Citation Information : Das AC, Das SJ, Panda S, Sharma D, Taschieri S, Fabbro MD. Adjunctive Effect of Doxycycline with Conventional Periodontal Therapy on Glycemic Level for Chronic Periodontitis with Type 2 Diabetes Mellitus Subjects. J Contemp Dent Pract 2019; 20 (12):1417-1423.

DOI: 10.5005/jp-journals-10024-2722

License: CC BY-NC 4.0

Published Online: 01-12-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aims: This study aimed to assess the use of doxycycline in adjunct to periodontal therapy on the glycemic levels for chronic periodontitis patients with type 2 diabetes mellitus (DM). Materials and methods: Fifty-one diabetic subjects with chronic periodontitis were selected and randomly assigned into 3 groups with 17 subjects each. Scaling and root planing (SRP) was done in group I, SRP and doxycycline was given in group II, and group III did not receive any periodontal treatment till 3 months. Probing pocket depth (PPD), clinical attachment level (CAL), plaque index (PI), gingival index (GI), and metabolic parameters were evaluated at baseline (day 0) and after 3 months (day 90). The statistical analysis was carried out using SPSS 17.0 software with significance fixed at 95% CI (p < 0.05). Results: The mean difference between baseline and day 90 for all periodontal parameters was significantly higher (p < 0.01) in group I and group II compared to control (group III). The metabolic parameters such as fasting plasma glucose (FPG), 2-hour postprandial plasma glucose (PPG), and glycated hemoglobin (HbA1c%) level were reduced in groups I and II compared to group III; however, only HbA1c% values were found significantly reduced (p < 0.01) at day 90. Group II showed significantly better metabolic parameters than group I at day 90. Conclusion: The adjunct of doxycycline to conventional periodontal therapy provides additional benefit in reducing glycemic level and improves periodontal health. Clinical significance: The prevalence of diabetes as well as periodontitis is increasing nowadays in the world. With treatment of periodontitis, it is found that there is reduction of glycemic level in diabetes. So it is an alert to health professionals about the relation of diabetes and periodontitis and so that they conduct a multidisciplinary treatment.


PDF Share
  1. Persson GR. What has ageing to do with periodontal health and disease? Int Dent J 2006;56(4 Suppl 1):240–249. DOI: 10.1111/j.1875-595X.2006.tb00108.x.
  2. Thornton-Evans G, Eke P, Wei L, et al. Periodontitis among adults aged ≥30 years - United States, 2009-2010. MMWR Suppl 2013;62(3): 129–135.
  3. Mealey BL, Rose LF. Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes 2008;15(2):135–141. DOI: 10.1097/MED.0b013e3282f824b7.
  4. Telgi RL, Tandon V, Tangade PS, et al. Efficacy of nonsurgical periodontal therapy on glycaemic control in type II diabetic patients: a randomized controlled clinical trial. J Periodontal Implant Sci 2013;43(4):177–182. DOI: 10.5051/jpis.2013.43.4.177.
  5. Sánchez-Zamora YI, Rodriguez-Sosa M. The role of MIF in type 1 and type 2 diabetes mellitus. J Diabetes Res 2014;2014:804519. DOI: 10.1155/2014/804519.
  6. Santacroce L, Carlaio RG, Bottalico L. Does it make sense that diabetes is reciprocally associated with periodontal disease? Endocr Metab Immune Disord Drug Targets 2010;10(1):57–70. DOI: 10.2174/187153010790827975.
  7. Taylor GW, Borgnakke WS. Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis 2008;14(3): 191–203. DOI: 10.1111/j.1601-0825.2008.01442.x.
  8. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002;30(3):182–192. DOI: 10.1034/j.1600-0528.2002.300304.x.
  9. Soskolne WA, Klinger A. The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol 2001;6(1):91–98. DOI: 10.1902/annals.2001.6.1.91.
  10. Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993;16(1):329–334. DOI: 10.2337/diacare.16.1.329.
  11. Mirnić J, Djurić M, Predin T, et al. Impact of the level of metabolic control on the non-surgical periodontal therapy outcomes in diabetes mellitus type 2 patients--clinical effects. Srp Arh Celok Lek 2013;141(11–12):738–743. DOI: 10.2298/SARH1312738M.
  12. Noack B, Genco RJ, Trevisan M, et al. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72(9):1221–1227. DOI: 10.1902/jop.2000.72.9.1221.
  13. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82(12):4196–4200. DOI: 10.1210/jcem.82.12.4450.
  14. Natali A, Toschi E, Baldeweg S, et al. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 2006;55(4):1133–1140. DOI: 10.2337/diabetes.55.04.06.db05-1076.
  15. Salvi GE, Collins JG, Yalda B, et al. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997;24(1):8–16. DOI: 10.1111/j.1600-051X.1997.tb01178.x.
  16. Mealey BL, Oates TW, American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77(8): 1289–1303. DOI: 10.1902/jop.2006.050459.
  17. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 2001;6(1):99–112. DOI: 10.1902/annals.2001.6.1.99.
  18. Iwamoto Y, Nishimura F, Nakagawa M, et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001;72(6):774–778. DOI: 10.1902/jop.2001.72.6.774.
  19. Gaikwad SP, Gurav AN, Shete AR, et al. Effect of scaling and root planing combined with systemic doxycycline therapy on glycemic control in diabetes mellitus subjects with chronic generalized periodontitis: a clinical study. J Periodontal Implant Sci 2013;43(2): 79–86. DOI: 10.5051/jpis.2013.43.2.79.
  20. Bharti P, Katagiri S, Nitta H, et al. Periodontal treatment with topical antibiotics improves glycemic control in association with elevated serum adiponectin in patients with type 2 diabetes mellitus. Obes Res Clin Pract 2013;7(2):e129–e138. DOI: 10.1016/j.orcp.2011.11.005.
  21. Sakellari D, Goodson JM, Kolokotronis A, et al. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 2000;27(1):53–60. DOI: 10.1034/j.1600-051x. 2000.027001053.x.
  22. Sorsa T, Tjäderhane L, Konttinen YT, et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38(5):306–321. DOI: 10.1080/07853890600800103.
  23. Wang N, Tian X, Chen Y, et al. Low dose doxycycline decreases systemic inflammation and improves glycemic control, lipid profiles, and islet morphology and function in db/db mice. Sci Rep 2017;7(1):14707. DOI: 10.1038/s41598-017-14408-7.
  24. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condtion. Acta Odontol Scand 1964;22(1):121–135. DOI: 10.3109/00016356408993968.
  25. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21(6):533–551. DOI: 10.3109/00016356309011240.
  26. Grossi SG, Skrepcinski FB, DeCaro T, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997;68(8):713–719. DOI: 10.1902/jop.1997.68.8.713.
  27. Salvi GE, Spets-Happonen S, Singer RE, et al. Reconstitution of a hyperinflammatory prostaglandin E2 response to Porphyromonas gingivalis challenge in severe combined immunodeficient mice. J Periodontol 2005;76(1):16–21. DOI: 10.1902/jop.2005.76.1.16.
  28. Frantzis TG, Reeve CM, Brown AL. The ultrastructure of capillary basement membranes in the attached gingiva of diabetic and nondiabetic patients with periodontal disease. J Periodontol 1971;42(7):406–411. DOI: 10.1902/jop.1971.42.7.406.
  29. Listgarten MA, Ricker FH, Laster L, et al. Vascular basement lamina thickness in the normal and inflamed gingiva of diabetics and non-diabetics. J Periodontol 1974;45(9):676–684. DOI: 10.1902/jop.1974.45.9.676.
  30. Seppälä B, Sorsa T, Ainamo J. Morphometric analysis of cellular and vascular changes in gingival connective tissue in long-term insulin-dependent diabetes. J Periodontol 1997;68(12):1237–1245. DOI: 10.1902/jop.1997.68.12.1237.
  31. Ramamurthy NS, Golub LM. Diabetes increases collagenase activity in extracts of rat gingiva and skin. J Periodontal Res 1983;18(1):23–30. DOI: 10.1111/j.1600-0765.1983.tb00331.x.
  32. Cianciola LJ, Park BH, Bruck E, et al. Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc 1982;104(5):653–660. DOI: 10.14219/jada.archive.1982.0240.
  33. Taylor GW, Burt BA, Becker MP, et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 1998;69(1):76–83. DOI: 10.1902/jop.1998.69.1.76.
  34. Nelson RG, Shlossman M, Budding LM, et al. Periodontal disease and NIDDM in Pima Indians. Diabetes Care 1990;13(8):836–840. DOI: 10.2337/diacare.13.8.836.
  35. Kiran M, Arpak N, Unsal E, et al. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol 2005;32(3):266–272. DOI: 10.1111/j.1600-051X. 2005.00658.x.
  36. Stewart JE, Wager KA, Friedlander AH, et al. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol 2001;28(4):306–310. DOI: 10.1034/j.1600-051x.2001.028004306.x.
  37. Rodrigues DC, Taba MJ, Novaes ABJ, et al. Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol 2003;74(9):1361–1367. DOI: 10.1902/jop.2003.74.9.1361.
  38. Promsudthi A, Pimapansri S, Deerochanawong C, et al. The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects. Oral Dis 2005;11(5):293–298. DOI: 10.1111/j.1601-0825.2005.01119.x.
  39. Faria-Almeida R, Navarro A, Bascones A. Clinical and metabolic changes after conventional treatment of type 2 diabetic patients with chronic periodontitis. J Periodontol 2006;77(4):591–598. DOI: 10.1902/jop.2006.050084.
  40. Madden TE, Herriges B, Boyd LD, et al. Alterations in HbA1c following minimal or enhanced non-surgical, non-antibiotic treatment of gingivitis or mild periodontitis in type 2 diabetic patients: a pilot trial. J Contemp Dent Pract 2008;9(5):9–16. DOI: 10.5005/jcdp-9-5-9.
  41. O'Connell PAA, Taba M, Nomizo A, et al. Effects of periodontal therapy on glycemic control and inflammatory markers. J Periodontol 2008;79(5):774–783. DOI: 10.1902/jop.2008.070250.
  42. Al-Zahrani MS, Bamshmous SO, Alhassani AA, et al. Short-term effects of photodynamic therapy on periodontal status and glycemic control of patients with diabetes. J Periodontol 2009;80(10):1568–1573. DOI: 10.1902/jop.2009.090206.
  43. Lee H-K, Choi S-H, Won KC, et al. The effect of intensive oral hygiene care on gingivitis and periodontal destruction in type 2 diabetic patients. Yonsei Med J 2009;50(4):529–536. DOI: 10.3349/ymj.2009.50.4.529.
  44. Seppälä B, Ainamo J. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. J Clin Periodontol 1994;21(3):161–165. DOI: 10.1111/j.1600-051X.1994.tb00297.x.
  45. Aldridge JP, Lester V, Watts TL, et al. Single-blind studies of the effects of improved periodontal health on metabolic control in type 1 diabetes mellitus. J Clin Periodontol 1995;22(4):271–275. DOI: 10.1111/j.1600-051X.1995.tb00147.x.
  46. Westfelt E, Rylander H, Blohmé G, et al. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol 1996;23(2):92–100. DOI: 10.1111/j.1600-051X.1996.tb00540.x.
  47. Janket S-J, Wightman A, Baird AE, et al. Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res 2005;84(12):1154–1159. DOI: 10.1177/154405910508401212.
  48. da Cruz GA, de Toledo S, Sallum EA, et al. Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus. J Periodontol 2008;79(7):1150–1157. DOI: 10.1902/jop.2008.070503.
  49. Yoon JW. Role of viruses in the pathogenesis of IDDM. Ann Med 1991;23(4):437–445. DOI: 10.3109/07853899109148087.
  50. Szopa TM, Titchener PA, Portwood ND, et al. Diabetes mellitus due to viruses--some recent developments. Diabetologia 1993;36(8): 687–695. DOI: 10.1007/BF00401138.
  51. Ryan ME, Ramamurthy NS, Golub LM. Tetracyclines inhibit protein glycation in experimental diabetes. Adv Dent Res 1998;12(2):152–158. DOI: 10.1177/08959374980120011201.
  52. Morrison EC, Ramfjord SP, Hill RW. Short-term effects of initial, nonsurgical periodontal treatment (hygienic phase). J Clin Periodontol 1980;7(3):199–211. DOI: 10.1111/j.1600-051X.1980.tb01963.x.
  53. Lowenguth RA, Greenstein G. Clinical and microbiological response to nonsurgical mechanical periodontal therapy. Periodontol 2000 1995;9(1):14–22. DOI: 10.1111/j.1600-0757.1995.tb00052.x.
  54. Al Mubarak S, Rass MA, Alsuwyed A, et al. A new paradigm between mechanical scaling and root planing combined with adjunctive chemotherapy for glycated hemoglobin improvement in diabetics. Int J Diabetes Mellitus 2010;2(3):158–164. DOI: 10.1016/j.ijdm.2010.08.006.
  55. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62–S69. DOI: 10.2337/dc10-S062.
  56. Bouma M, Dekker JH, de Sonnaville JJ, et al. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care 1999;22(6): 904–907. DOI: 10.2337/diacare.22.6.904.
  57. Santos CM, Lira-Junior R, Fischer RG, et al. Systemic antibiotics in periodontal treatment of diabetic patients: a systematic review. PLoS One 2015;10(12):e0145262. DOI: 10.1371/journal.pone.0145262.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.